At what state are we leaving earth to the next generation?
We’re likely living in a post-400 ppm world. Here’s what it means to scientists that study the climate.
LG really, really wants your next TV, smartwatch, and car to use an OLED panel and, preferably, one that’s come off its new $8.71bn production line. The company’s panel arm, LG Display, has announced a whopping 1.84 trillion South Korean Won investment into a brand new facility dubbed P10, which will cater for what LG predicts will be blockbuster demand for OLED in a range of sizes.
That $8.71bn is only the tip of the iceberg, mind, and the plant — to be constructed in Paju, Gyeonggi Province, Korea — is expected to eventually cost more than five times that amount.
Continue reading “LG pumps $8.7bn into OLED for your car, TV and wrist” »
A week and a half ago, we learned that Tesla is on a quest to hire more engineers to accelerate the development of its self-driving car technologies.
Tesla was already no slouch in the autonomous-vehicle world, having released its Autopilot feature into the wild just over a month ago.
We sampled Autopilot as soon as it hit the streets and were quite impressed, to put it mildly.
An Italian surgeon hopes to perform the first-ever head transplant. Is he a genius or a crank?
Amazon delivered a lovely update on its ‘Prime Air’ project today — almost exactly two years after it showed the first iteration of its drone. You know, the flying delivery drone that some thought was a massive joke meant for April 1st. Included are some high-res shots and two new videos.
Amazon releases a vid with a new Prime Air drone design https://t.co/HCIjXZQkWN
Researchers have found that changing a single gene in worms leads to a 70 percent increase in life span. Can this be replicated one day in humans? Catch #Breakthrough at 9pm EDT on the National Geographic Channel tonight to learn about the future of aging.
The results are mixed, of course, but it’s fascinating to watch the neural network make mistakes (and sometimes correct itself) in real time. The open source program being used is called NeuralTalk and was first unveiled last year, with the researchers providing updates on the network’s capabilities since. Other companies and institutions are working on similar technology. Last month, for example, Facebook unveiled a prototype neural network that’s intended to help blind people by describing pictures.
London, UK, November, 19, 2015 (PRWEB UK) 19 November 2015.
What matters in beauty is perception. Perception is how you and other people see you, and this perception is almost always biased. Still, healthy people look more attractive despite their age and nationality.
This has enabled the team of biogerontologists and data scientists, who believe that in the near future machines will be able to get a lot of vital medical information about people’s health by just processing their photos, to develop a set of algorithms that can accurately evaluate the criteria linked to perception of human beauty and health where it is most important – the human face. But evaluating beauty and health is not enough. The team’s challenge is to find effective ways to slow down ageing and help people look healthy and beautiful.
Just as the development of antibiotics revolutionized the treatment and prevention of bacterial infections in the mid-20th century, MIT’s Dr. Todd Rider has invented DRACOs, a novel broad-spectrum antiviral drug that has the potential to revolutionize the treatment and prevention of virtually all viral infections. Dr. Rider’s DRACOs approach and results have been called “visionary” by the White House (National Bioeconomy Blueprint, April 2012, p. 9), named one of the best inventions of the year by Time magazine (November 28, 2011, pp. 58, 78), and featured on the BBC Horizons TV program (2013).
However, research on DRACOs has entered the well-known “Valley of Death” in which a lack of funding prevents DRACOs, and many other promising new drugs, from being developed and advancing toward human medical trials. To progress DRACOs research it needs to be demonstrated against clinically relevant viruses (i.e; HSV). To that end an IndieGoGo campaign (http://igg.me/at/EndTheVirus) was started on October 13, 2015.
Donate and Learn More on IndieGoGo.http://igg.me/at/EndTheVirus
